Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DF277 to placebo for otic eczema has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otic Eczema

Drugs mentioned

• DF277

Snippet

Sponsor: Salvat | Conditions: Otic Eczema | Phase 3 | Status: COMPLETED | Results posted: 2017-04-14